stockrowCintas Corporation
CTAS Industrials Specialty Business Services
Cintas Corporation’s revenue for fiscal 2026 (year ended May 2026) was $11.3 billion, up 8.94% from fiscal 2025.
- Revenue
- +10.9%
- EPS
- +12.5%
- Free cash flow
- +48.7%
- Total debt
- +0.13%
Quarter to August 2026, against a year earlier
Follow CTAS
Alert me
Cintas Corporation (CTAS) EPS (diluted)
Cintas Corporation's EPS (diluted) for fiscal 2026 was $4.91, up 11.6% from $4.40 in fiscal 2025. Over the twelve months to 31 August 2026 it was $5.07. Over the past ten years it has ranged from $0.91 (fiscal 2015) to $4.91 (fiscal 2026) — the current reading is the highest in ten years. EPS (diluted) has risen for 9 consecutive fiscal years. Cintas Corporation ranks 5th of 34 Specialty Business Services companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2026 | $4.91 | 11.59% |
| FY2025 | $4.40 | 16.17% |
| FY2024 | $3.79 | 16.63% |
| FY2023 | $3.25 | 11.50% |
| FY2022 | $2.91 | 13.77% |
| FY2021 | $2.56 | 26.26% |
| FY2020 | $2.03 | 1.50% |
| FY2019 | $2.00 | 5.69% |
| FY2018 | $1.89 | 72.60% |
| FY2017 | $1.10 | (29.47%) |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Aug 2026 | $1.36 | 7.94% |
| May 2026 | $1.26 | 1.61% |
| Feb 2026 | $1.24 | 2.48% |
| Nov 2025 | $1.21 | 0.83% |
| 43 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| UNF Unifirst Corporation compare | $6.01 |
| CTAS Cintas Corporation | $5.07 |
| ULS UL Solutions Inc. compare | $2.51 |
| DLB Dolby Laboratories compare | $2.35 |
| CPRT Copart, Inc. compare | $1.55 |
| ARMK Aramark compare | $1.43 |
| AMTM Amentum Holdings, Inc. compare | $0.83 |
| RELX RELX PLC compare | — |
| RTO Rentokil Initial PLC compare | — |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CTAS
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement